Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome - A meta-analysis of randomised trials

被引:43
作者
Johnson, Neil [1 ]
机构
[1] Univ Auckland, Green Lane Clin Ctr, Auckland, New Zealand
关键词
anovulation; clomiphene; infertility; meta-analysis; metformin; ovulation induction; polycystic ovary syndrome; CLOMIPHENE CITRATE; OVULATION INDUCTION;
D O I
10.1111/j.1479-828X.2010.01274.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: There are differences in opinion as to whether metformin should play a role in the primary treatment of anovulatory infertility for women with polycystic ovary syndrome (PCOS). Aim: The aim of this study was to ascertain the best available evidence comparing metformin versus clomiphene treatment for non-obese women with anovulatory infertility related to PCOS. Methods: Meta-analysis of available data from randomised controlled trials that examined metformin versus clomiphene for the subgroup of women in the lower body mass index (BMI) range (primarily non-obese). Primary outcomes were clinical pregnancy and live birth. Results: For women with BMI <= 30-32 kgm(2), clinical pregnancy rates were 36.7% (52/42) for metformin and 35.7% (51/43) for clomiphene; live birth rates were 30.3% (43/42) for metformin and 30.8% (44/43) for clomiphene. Conclusion: The available randomised trial data show no significant difference in effectiveness of metformin versus clomiphene as ovulation induction agents for non-obese women with anovulatory PCOS. Metformin and clomiphene are both suitable options for first-line treatment.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 21 条
[1]  
[Anonymous], FERT SOC AUSTR ANN S
[2]  
[Anonymous], NAT I CLIN EXCELLENC
[3]  
[Anonymous], FERTIL STERIL
[4]   Should obese women with polycystic ovary syndrome receive treatment for infertility? Given the risks such women will face in pregnancy, they should lose weight first [J].
Balen, AH ;
Dresner, MT ;
Scott, EM ;
Drife, JO .
BRITISH MEDICAL JOURNAL, 2006, 332 (7539) :434-435
[5]   SONOGRAPHIC DETERMINATION OF A POSSIBLE ADVERSE EFFECT OF CLOMIPHENE CITRATE ON ENDOMETRIAL GROWTH [J].
GONEN, Y ;
CASPER, RF .
HUMAN REPRODUCTION, 1990, 5 (06) :670-674
[6]   Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study [J].
Jensen, Allan ;
Sharif, Heidi ;
Frederiksen, Kirsten ;
Kjaer, Susanne Krueger .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :580-582
[7]   PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene [J].
Johnson, N. P. ;
Stewart, A. W. ;
Falkiner, J. ;
Farquhar, C. M. ;
Milsom, S. ;
Singh, V. -P. ;
Okonkwo, Q. L. ;
Buckingham, K. L. .
HUMAN REPRODUCTION, 2010, 25 (07) :1675-1683
[8]   An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome [J].
Karimzadeh, Mohammad Ali ;
Javedani, Mojgan .
FERTILITY AND STERILITY, 2010, 94 (01) :216-220
[9]   Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome [J].
Legro, Richard S. ;
Barnhart, Huiman X. ;
Schlaff, William D. ;
Carr, Bruce R. ;
Diamond, Michael P. ;
Carson, Sandra A. ;
Steinkampf, Michael P. ;
Coutifaris, Christos ;
McGovern, Peter G. ;
Cataldo, Nicholas A. ;
Gosman, Gabriella G. ;
Nestler, John E. ;
Giudice, Linda C. ;
Leppert, Phyllis C. ;
Myers, Evan R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (06) :551-566
[10]   Obesity, polycystic ovary syndrome, infertility treatment - Lifestyle modification is paramount [J].
Lord, JM ;
Norman, RJ .
BRITISH MEDICAL JOURNAL, 2006, 332 (7541) :609-609